FDA Marks :"We’re going to be encouraging people in the direction of accelerated approval when they can, especially for rare diseases. Because for rare diseases, and especially things that are like neurodegenerative diseases, it could take a long time to get to clinical endpoints."
Neurodegenerative diseases is where Anavex shines !!!